Back
ESC Premium Access

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Session: Anticoagulation in atrial fibrillation
Topic: Atrial fibrillation (AF)
Speaker: Doctor P. Noseworthy (Rochester, US)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
3 presentations
0 follower

9 more presentations in this session

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)

Access
Abstract
Slides
Video
Thumbnail

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Speaker: Associate Professor L. Friberg (Stockholm, SE)

Access
Abstract
Slides
Video
Thumbnail

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)

Access
Abstract
Slides
Video
Thumbnail

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)

Access
Abstract
Slides
Video
Thumbnail

Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Anticoagulation in atrial fibrillation

Speakers: Doctor P. Noseworthy, Assistant Professor B. Hornestam, Associate Professor L. Friberg, Doctor P. Noseworthy, Mr J. Butt...
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb